Alto Neuroscience, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue -1.37M-1.38M
Gross Profit -1.37M-1.38M
Operating items
Research & Development 30.29M47.00M
Selling, General & Administrative 7.52M21.61M
Operating Expenses 37.81M68.61M
Operating Income -37.81M-68.61M
EBIT -37.81M-68.61M
Non-operating items
Interest & Investment Income 2.35M8.85M
Non Operating Income 1.50M7.18M
Net income details
EBT -36.83M-61.13M
Profit After Tax -36.30M-61.43M
Income from Continuing Operations -36.83M-61.13M
Consolidated Net Income -36.83M-61.13M
Income towards Parent Company -36.83M-61.13M
Net Income towards Common Stockholders -36.83M-61.13M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 17.53M26.97M
EBITDA -37.81M-68.61M